Skip to main navigation Skip to main content
  • KSCN
  • E-Submission

CNR : Clinical Nutrition Research

OPEN ACCESS
ABOUT
BROWSE ARTICLES
EDITORIAL POLICIES
FOR CONTRIBUTORS

Page Path

2
results for

"Hyperammonemia"

Article category

Keywords

Publication year

Authors

"Hyperammonemia"

Original Article

[English]

Hepatic encephalopathy (HE) associated with liver failure is accompanied by hyperammonemia, severe inflammation, depression, anxiety, and memory deficits as well as liver injury. Recent studies have focused on the liver-brain-inflammation axis to identify a therapeutic solution for patients with HE. Lipocalin-2 is an inflammation-related glycoprotein that is secreted by various organs and is involved in cellular mechanisms including iron homeostasis, glucose metabolism, cell death, neurite outgrowth, and neurogenesis. In this study, we investigated that the roles of lipocalin-2 both in the brain cortex of mice with HE and in Neuro-2a (N2A) cells. We detected elevated levels of lipocalin-2 both in the plasma and liver in a bile duct ligation mouse model of HE. We confirmed changes in cytokine expression, such as interleukin-1β, cyclooxygenase 2 expression, and iron metabolism related to gene expression through AKT-mediated signaling both in the brain cortex of mice with HE and N2A cells. Our data showed negative effects of hepatic lipocalin-2 on cell survival, iron homeostasis, and neurite outgrowth in N2A cells. Thus, we suggest that regulation of lipocalin-2 in the brain in HE may be a critical therapeutic approach to alleviate neuropathological problems focused on the liver-brain axis.

Citations

Citations to this article as recorded by  
  • Astrocyte-secreted lipocalin-2 elicits bioenergetic failure-induced neuronal death that is causally related to high fatality in a mouse model of hepatic encephalopathy
    Ching-Yi Tsai, Chin-Lai Lee, Jacqueline C.C. Wu
    Neurochemistry International.2024; 178: 105800.     CrossRef
  • Lipocalin-2 as a mediator of neuroimmune communication
    Ruqayya Afridi, Jae-Hong Kim, Anup Bhusal, Won-Ha Lee, Kyoungho Suk
    Journal of Leukocyte Biology.2024; 116(2): 357.     CrossRef
  • 17 View
  • 0 Download
  • 2 Crossref
Case Report
[English]
Nutritional Management in a Patient with Citrullinemia Type 1
Hyejin Kang, Mihyang Kim, Ji Hyun Lee
Clin Nutr Res 2021;10(3):268-277.   Published online July 20, 2021
DOI: https://doi.org/10.7762/cnr.2021.10.3.268

For patients with citrullinemia type 1, nutritional management is essential to prevent the occurrence of complications associated with hyperammonemia. This report describes a patient who had been receiving nutrition intervention for more than 3 years. A newborn diagnosed with hyperammonemia due to citrullinemia visited Ajou University Hospital and was referred to the nutrition team. After receiving acute treatment, the infant was regularly fed with specialized formula. A protein-restricted diet is recommended for maintaining normal development and achieving long-term survival. Through continuous provision of nutritional intervention, the child showed normal growth and development, and the energy-protein supply was maintained appropriately. This case clearly shows the importance of medical nutrition therapy for patients with citrullinemia.

Citations

Citations to this article as recorded by  
  • Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
    Saumya Nishanga Heendeniya, Suxiang Chen, Saadia Bhatti, Qurat Ul Ain Zahra, Kamal Rahimizadeh, Bal Hari Poudel, Stephen D. Wilton, Rakesh N. Veedu
    Experimental Biology and Medicine.2025;[Epub]     CrossRef
  • Visualization of argininosuccinate synthetase by in silico analysis: novel insights into citrullinemia type I disorders
    Xia Gu, Wenhui Mo, Guiying Zhuang, Congcong Shi, Tao Wei, Jinze Zhang, Chiaowen Tu, Yao Cai, Biwen Liao, Hu Hao
    Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
  • Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G>A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran: A case series
    Maryam Hassanlou, Maryam Abiri, Sirous Zeinali
    International Journal of Reproductive BioMedicine (IJRM).2023; 20(12): 1047.     CrossRef
  • Case report: Diagnosis of ADCY5-related dyskinesia explaining the entire phenotype in a patient with atypical citrullinemia type I
    Audrey Pontrucher, Magalie Barth, Alban Ziegler, Juan Manuel Chao de la Barca, Delphine Mirebeau-Prunier, Pascal Reynier, Chadi Homedan
    Frontiers in Neurology.2023;[Epub]     CrossRef
  • 10 View
  • 0 Download
  • 4 Crossref